Frank Vandekerckhove Jaarcongres VVOG Genk, 10 oktober 2013

Slides:



Advertisements
Similar presentations
ART-IVF: the Long and Short of it Professor Ernest Hung Yu NG Department of Obstetrics & Gynaecology The University of Hong Kong.
Advertisements

Role of Anti-Mullerian hormone in prediction of Assisted Reproductive Technology outcomes Leili Safdarian M.D. Khadigeh Khosravi M.D. Marzieh Agha Hosseini.
Do you have what it takes – from follicle to healthy baby?
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Effect of GnRH-agonist downregulation on serum AMH levels: a prospective cohort study with repeated measurements P. Drakopoulos1, A. van de Vijver1, J.
David Charles, B.S. ; Kate D. Schoyer, M.Da
Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.
Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation?  Micah.
Antagonists in poor-responder patients
Nicole Banks, M. D. , George Patounakis, M. D. , Ph. D
A GnRH agonist and exogenous hormone stimulation protocol has a higher live-birth rate than a natural endogenous hormone protocol for frozen-thawed blastocyst-stage.
Jocelyn M. Wessels, Ph. D. , Vanessa R. Kay, B. Sc. , Nicholas A
Developmental programming: prenatal testosterone excess disrupts anti-Müllerian hormone expression in preantral and antral follicles  Almudena Veiga-Lopez,
Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization.
Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D
Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve  László F.J.M.M Bancsi,
Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization  Antonio La Marca,
Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization–intracytoplasmic.
Antimüllerian hormone levels and numbers and sizes of antral follicles in regularly menstruating women of reproductive age referenced to true ovulation.
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction  Antonio La Marca, Giovanni D’Ippolito 
N. la Cour Freiesleben, T. A. Gerds, J. L. Forman, J. D. Silver, A
The predictive value for in vitro fertility delivery rates is greatly impacted by the method used to select the threshold between normal and elevated.
Patient-tailored ovarian stimulation for in vitro fertilization
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer 
Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages  Maribel.
Combining cycle day 7 follicle count with the basal antral follicle count improves the prediction of ovarian response  Fatih Durmusoglu, M.D., Koray Elter,
Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth  Scott M. Nelson, M.R.C.O.G.,
Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing.
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.
Biomarkers of ovarian response: current and future applications
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
Antral follicle count: absence of significant midlife decline
Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting  Karl R Hansen, M.D., Ph.D., Jamie L Morris,
Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.
Microdose follicular phase gonadotropin-releasing hormone agonists (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization5 
Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.
Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool  Richard.
Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders—an observational pilot study  Frederic Mitri,
Links between age at menarche, antral follicle count, and body mass index in African American and European American women  Sonya M. Schuh, Ph.D., Julia.
How to do a study? Prof. P. Devroey.
A new approach to ovarian reserve testing
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D. 
Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation  Nam D. Tran, M.D., Ph.D., Lusine Aghajanova, M.D.,
Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis.
Mitchell P. Rosen, M. D. , Erica Johnstone, M. D. , Charles E
Jeff G. Wang, Nataki C. Douglas, Gary S. Nakhuda, Janet M
Dr. Kenneth Egwuda MBBS, PGA-ART(Lon), ESGE(Belg.),FMAS,FWACS,FMCOG
Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction–intrauterine insemination to in vitro.
Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection  Dorothea M.
Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening  Tarun Jain, M.D., Michael.
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.
The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is.
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.
Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics.
Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients  Scott M. Nelson, Ph.D., Martina C. Messow,
Lower levels of inhibin A and pro-αC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human.
First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for.
Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists 
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D
Effectiveness of human menopausal gonadotropin versus recombinant follicle- stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive.
Timing of oocyte maturation and egg collection during controlled ovarian stimulation: a randomized controlled trial evaluating manual and automated measurements.
Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve  Norbert.
Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle- stimulating hormone (FSH) in normoandrogenic ovulatory women.
A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders  Hakan Cakmak, M.D., Nam D. Tran,
Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing.
Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles2 
A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.
Day-5 inhibin B serum concentrations and antral follicle count as predictors of ovarian response and live birth in assisted reproduction cycles stimulated.
Presentation transcript:

Frank Vandekerckhove Jaarcongres VVOG Genk, 10 oktober 2013 Plaats van antrale follikelmetingen bij het bepalen van de ovariële reserve Frank Vandekerckhove Jaarcongres VVOG Genk, 10 oktober 2013

Testen ovariële reserve (ORT) Inschatten respons ovariële stimulatie OHSS Lage respons Counseling voorbereiden Individualiseren behandelingsplan Maximaliseren slaagkansen

Vereisten ORT Eenvoudig Betrouwbaar en reproduceerbaar Goedkoop Snel resultaat Onafhankelijk cyclustijdstip Patient compliance

AFC (2D)

A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles John L Frattarelli, MD, Andrew J Levi, MD, Bradley T Miller, MD and James H Segars, MD Fertility and Sterility Volume 80, Issue 2, Pages 350-355 (August 2003) DOI: 10.1016/S0015-0282(03)00664-2

Prospectieve cohort studie N: 289 AFC: 2-10 mm Cancelled: < 3 follikels; E2 < 500 pg/ml

FIGURE 1 Association between antral follicle count (AF) and rates of cycle cancellation and pregnancy. An antral follicle count ≤ 4 was associated with a significant increase in cycle cancellation (41.0% vs. 6.4%) and decrease in pregnancy success in patients without cycle cancellation. Frattarelli. Predictive value of antral follicles in IVF.Fertil Steril 2003.

Voorspellende waarde voor low response Review Voorspellende waarde voor low response Combinatie van ORT (review) versus AFC (2005) ORT: FSH, E2, inhibine B, AMH, AFC, OV, flow, leeftijd, CCCT 11 artikels: 7 cohort 4 case control Slechts 1 studie met zwangerschapscijfers

ROC space with the reported sensitivities and specificities of the multivariate models. ROC space with the reported sensitivities and specificities of the multivariate models. The closed circles represent the estimates from cohort studies whereas the open circles represent the estimates from case–control studies. Furthermore, two summary ROC curves are shown Verhagen T et al. Hum. Reprod. Update 2008;14:95-100

AFC (3D) AFC (3D)

AFC (3D)

Intraobserver and interobserver reliability of automated antral follicle counts made using three-dimensional ultrasound and SonoAVC S. DEB, K. JAYAPRAKASAN, B. K. CAMPBELL, J. S. CLEWES, I. R. JOHNSON and N. J. RAINE-FENNING Ultrasound Obstet Gynecol 2009; 33: 477–483

Observationele studie N: 55 1 performer 3D AVC Analyse off-line P1: 1 X P2: 2 X AFC: 2-10 mm; dag 2-5 Cave: hertellingen

2D 3D 3D AVC

Observationele studie 1 observer AFC: =< 9 mm; dag 2-5 1aire outcome variabele: CPR

The figure shows correlation coefficient (R) and regression coefficient (R2) between 2.1 and 4.0 mm follicles and the total dose of gonadotrophin used, total number of oocytes, number of mature oocytes and number of cleaved embryos. The figure shows correlation coefficient (R) and regression coefficient (R2) between 2.1 and 4.0 mm follicles and the total dose of gonadotrophin used, total number of oocytes, number of mature oocytes and number of cleaved embryos. The correlation between the follicles and the total number of oocytes, mature oocytes and cleaved embryos was significant (P < 0.05); however, did not have significant correlation with the total dose of gonadotrophin. Deb S et al. Hum. Reprod. 2009;24:2124-2132

The figure shows receiver operator characteristic (ROC) curves of different variables predictive of pregnancy on univariate analysis. The figure shows receiver operator characteristic (ROC) curves of different variables predictive of pregnancy on univariate analysis. The area under the curve (AUC) for the antral follicles measuring 2.0–4.0 mm was the maximum (0.694), albeit not significantly different to that of age (0.634), fertilized oocytes (0.633) and cleaved embryos (0.632). Deb S et al. Hum. Reprod. 2009;24:2124-2132

Deb S et al. Hum. Reprod. 2009;24:2124-2132

Review 11 studies OHSS gedefinieerd volgens aantal eicellen, E2, OHSS symptomen AMH cut-off: 1.59-7.00 ng/ml AFC cut-off: 9-18

AMH and AFC in the prediction of an excessive response. AMH and AFC in the prediction of an excessive response. Note: Regardless of the number of cut-offs mentioned per study, only one cut-off was taken into analysis. For the observed values of sensitivity–specificity points, all cut-offs are displayed. Broer S et al. Hum. Reprod. Update 2011;17:46-54

The predictive value of antral follicle count remains unchanged across the menstrual cycle Luk Rombauts, M.D., Ph.D., C.R.E.I., Joseph L. Onwude, M.Sc., Hong W. Chew, M.B.B.S. and Beverley J. Vollenhoven, Ph.D., C.R.E.I. Fertility and Sterility Volume 96, Issue 6, Pages 1514-1518 (December 2011) DOI: 10.1016/j.fertnstert.2011.09.005

Retrospectieve studie N: 3117 Poor response: < 4 eicellen OPU Cave: AFC 19 (IQR 11-31)

Figure 1 Receiver operating characteristic curves (ROCs) for different subgroups. (Top) Cycle day; (middle) endometrial type; (bottom) endometrial thickness.

A characterization of the relationship of ovarian reserve markers with age Mitchell P. Rosen, M.D., Erica Johnstone, M.D., Charles E. McCulloch, Ph.D., Sonya M. Schuh-Huerta, Ph.D., Barbara Sternfeld, Ph.D., Renee A. Reijo-Pera, Ph.D. and Marcelle I. Cedars, M.D. Fertility and Sterility Volume 97, Issue 1, Pages 238-243 (January 2012) DOI: 10.1016/j.fertnstert.2011.10.031

Observationele studie Gezonde personen ORT markers op dag 2-4 Toetsen aan histologische gegevens in dezelfde leeftijdsgroep

Figure 1 Serum markers of ovarian reserve with age.

Review 55 studies Poor response: =< 4 eicellen OPU =< 4 follikels < 12 mm

ROC curves of age and ORT in the prediction of poor response and ongoing pregnancy. ROC curves of age and ORT in the prediction of poor response and ongoing pregnancy. (A) Poor response prediction based on age and ORT. The ROC curves of age or age combined with a single or more ORT are depicted. The ROC curves for ‘Age + AMH’, ‘Age + AMH + AFC’ and ‘Age + AMH + AFC + FSH’ run toward the upper left corner, indicating a good capacity to discriminate between normal and poor responders at certain cut-off levels. (B) Ongoing pregnancy prediction based on age and ORT. The ROC curves age or age combined with one or more ORT run almost parallel to or even cross the X = Y line, indicating that the tests are useless for pregnancy prediction. AFC, antral follicle count; AMH, anti-Müllerian hormone; FSH, follicle stimulating hormone; ORT, ovarian reserve test; ROC, receiver-operating characteristic. Broer S L et al. Hum. Reprod. Update 2013;19:26-36

Biomarkers of ovarian response: current and future applications Scott M. Nelson, Ph.D. Fertility and Sterility Volume 99, Issue 4, Pages 963-969 (March 2013) DOI: 10.1016/j.fertnstert.2012.11.051

Figure 1 Scatter plots and correlations (Pearson correlation coefficients) for log 10 primordial follicle (PF) counts versus ovarian reserve test results. (naar Hansen et al., 2011)

Figure 2 5.6 ng/ml 2.8 ng/ml 0.98ng/ml Antimüllerian hormone (AMH) stratified individualization of treatment as used by the author. Ovarian response categories dictate risk, and treatment strategies are designed to minimize risk while maximizing oocyte yield within each response category. Negligible response means that the conventional criteria for triggering (three follicles ≥17 mm) is unlikely to be achieved. For all antagonist cycles with an excessive response, an agonist trigger is adopted. The AMH measurements are for the AMH Gen II assay, and the values are in pmol/L. The suggested antral follicle count (AFC) thresholds are based on the correlation of AMH and AFC and associated response category literature (30, 65). 0.14 ng/ml

Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good- prognosis patients Joan-Carles Arce, M.D., Ph.D., Antonio La Marca, M.D., Ph.D., Bjarke Mirner Klein, Ph.D., Anders Nyboe Andersen, M.D. and Richard Fleming, Ph.D. Fertility and Sterility Volume 99, Issue 6, Pages 1644-1653.e1 (May 2013) DOI: 10.1016/j.fertnstert.2012.12.048

Herverwerking resultaten RCT: recFSH of urFSH bij antagonisten AFC => 10 Dag 2-3; AFC 2-10 mm Poor response: =< 3 eicellen OPU of onderbreking High response: => 15 eicellen of onderbreking

Figure 1 Box and whisker plots for antimüllerian hormone (AMH), follicle-stimulating hormone (FSH), inhibin B, and antral follicle count (AFC) at start of stimulation in patients with various numbers of oocytes retrieved after stimulation with highly purified human menopausal gonadotropin (hphMG) or recombinant FSH in a gonadotropin-releasing hormone (GnRH) antagonist protocol. Values are median (lines), 25th–75th percentile (boxes), and 10th–90th percentile (whiskers). hphMG: ≤3 (n = 47), 4–7 (n = 124), 8–14 (n = 145), 15–19 (n = 38), ≥ 20 (n = 18); recombinant FSH: ≤3 (n = 25), 4–7 (n = 112), 8–14 (n = 147), 15–19 (n = 55), ≥ 20 (n = 30).

Figure 2 Receiver operating characteristic (ROC) curve analysis showing the predictive values of antimüllerian (AMH), follicle-stimulating hormone (FSH), inhibin B, and antral follicle count (AFC) at start of stimulation for estimation of poor ovarian response (≤3 oocytes retrieved or cycle cancellation due to poor response) and high response (≥15 oocytes retrieved or cycle cancellation due to excessive response), respectively, after controlled ovarian stimulation in patients treated with highly purified human menopausal gonadotropin (hphMG) or recombinant FSH in a gonadotropin-releasing hormone (GnRH) antagonist protocol. The diagonal line is the reference line of no discrimination (area under the curve = 0.5).

Evaluatie AFC Eenvoudig  Betrouwbaar en reproduceerbaar  Goedkoop Snel resultaat  Onafhankelijk cyclustijdstip Patient compliance 

Evaluatie AFC Eenvoudig  Betrouwbaar en reproduceerbaar  Goedkoop Snel resultaat  Onafhankelijk cyclustijdstip Patient compliance 